WHO ICTRP trial
Treatment of amblyopia with atropine
JPRN-UMIN000044731 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000044731 |
|---|---|
| Public title | Treatment of amblyopia with atropine |
| Scientific title | Treatment of amblyopia with atropine - Atropine treatment |
| Primary sponsor | Hiroshima University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | amblyopia |
| Registration date | Feb 7, 2021 |
| Target size | 30 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: